QUICK POLL
If imatinib, nilotinib, and dasatinib are all approved for front-line therapy of newly diagnosed chronic phase (CP) chronic myelogenous leukemia (CML), what would you recommend as front-line therapy for a 42-year-old man who presents with high-risk CML by both the Sokal and Hasford (Euro) scoring systems and who has no matched sibling donor?
Clinical Dialogue: Update on Psychopharmacology
April 30 - May 1, 2010
New York, New York
Sheraton New York Hotel and Towers
Cancellation
We regret to inform you that the Clinical Dialogue: Update on Psychopharmacology 2010 due to be held April 30 – May 1, 2010 in New York, New York has been cancelled. This decision was predicated on the lack of financial support in part due to the current economic climate. While Imedex and the meeting chairs have made every effort over the last few months to ensure the meeting would be able to move forward, it has become apparent that we would have no recourse but to cancel the meeting.
Refunds will be issued to all those who have registered and paid as soon as possible. No action is needed on your part to receive the refund. An Imedex Customer Service Representative will contact you via email or fax once the refund has been issued. Please contact us if you have any questions or concerns.
On behalf of Imedex and the meeting chairs we sincerely apologize for any inconvenience this decision may cause, but we hope you understand the reasons for this choice. We can assure you that such decisions are not taken lightly. Thank you for your interest.
Letter from the Chairs
Dear Colleague:
It is with great pleasure that we invite you back to New York City for the 2010 Clinical Dialogue: Update on Psychopharmacology. This educational conference will provide you with the opportunity to enhance your knowledge on new and upcoming management techniques and treatments of patients with psychotic and mood disorders.
Agenda topics include an expert look at the updated APA unipolar and bipolar treatment guidelines, new developments in brain stimulation modalities and the impact on clinical practice, and considerations in the management of psychotic symptoms in patients with dementia.
We received great feedback on the level of audience participation at last year’s meeting, so we will continue to offer expert panel and clinical case discussions. 2009 attendees described the meeting as “excellent” with “relevant and useful material.”
We look forward to sharing essential clinical information with you at this important educational forum. Space is limited so we encourage you to register early to guarantee your seat!
Sincerely,
Jeffrey A. Lieberman, MD
T. Scott Stroup, MD, MPH
Madhukar Trivedi, MD
ORGANIZER
Imedex
4325 Alexander Drive
Alpharetta, GA 30022-3740 USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
Email: meetings@imedex.com
Web: www.imedex.com
Important Dates
Regular Registration Deadline
April 22, 2010
Presentation Dates
April 30 – May 1, 2010
Quotes from Your Colleagues:
"Thank you for this excellent conference in psychopharmacology"
"Very good meeting and many new ideas"
"The material presented was relevant and useful"
"Great conference and affordable for the part time community psychiatrist – I will come back next year and bring my colleagues"
Imedex is a brand and assumed name used by Imedex, LLC (hereby referred to as Imedex). Imedex is solely responsible for this agenda’s content. Although Imedex attempts to ensure that the information in our program is accurate and timely, matters and opinions discussed and/or presented with respect to clinical matters are those of the discussion participants only, and not necessarily those of Imedex. Moreover, although Imedex attempts to identify and integrate the most qualified medical professionals in our program, TO THE FULLEST EXTENT PERMITTED BY LAW, IMEDEX EXPRESSLY DISCLAIM ALL WARRANTIES, EITHER EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, NON-INFRINGEMENT OF THIRD PARTIES’ RIGHTS, AND FITNESS FOR A PARTICULAR PURPOSE, WITH RESPECT TO THE CONTENT PRESENTED. IMEDEX FURTHER MAKES NO REPRESENTATIONS OR WARRANTIES ABOUT THE ACCURACY, RELIABILITY, COMPLETENESS OR TIMELINESS OF THE CONTENT OR ANY MATERIAL PRESENTED.
In addition, the material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.
Neither Imedex nor any of its subsidiaries or affiliates is affiliated with or formally endorsed by a medical society.
©2009 Imedex®, LLC. All rights reserved.
Reproduction in whole or part is prohibited without prior written consent from Imedex and contributing faculty.